Proteomics Center of Excellence, Departments of Molecular Biosciences, Chemistry, and the Feinberg School of Medicine, Northwestern University, Evanston, Illinois 60202, United States.
Department of Chemistry, Carl R. Woese Institute for Genomic Biology, Cancer Center at Illinois, University of Illinois at Urbana─Champaign, Urbana, Illinois 61801, United States.
Anal Chem. 2024 Mar 19;96(11):4455-4462. doi: 10.1021/acs.analchem.3c04758. Epub 2024 Mar 8.
The functions of proteins bearing multiple post-translational modifications (PTMs) are modulated by their modification patterns, yet precise characterization of them is difficult. MEK1 (also known as MAP2K1) is one such example that acts as a gatekeeper of the mitogen-activating protein kinase (MAPK) pathway and propagates signals via phosphorylation by upstream kinases. In principle, top-down mass spectrometry can precisely characterize whole MEK1 proteoforms, but fragmentation methods that would enable the site-specific characterization of labile modifications on 43 kDa protein ions result in overly dense tandem mass spectra. By using the charge-detection method called individual ion mass spectrometry, we demonstrate how complex mixtures of phosphoproteoforms and their fragment ions can be reproducibly handled to provide a "bird's eye" view of signaling activity through mapping proteoform landscapes in a pathway. Using this approach, the overall stoichiometry and distribution of 0-4 phosphorylations on MEK1 was determined in a cellular model of drug-resistant metastatic melanoma. This approach can be generalized to other multiply modified proteoforms, for which PTM combinations are key to their function and drug action.
具有多种翻译后修饰(PTM)的蛋白质的功能受其修饰模式调节,但精确表征它们具有一定难度。丝裂原活化蛋白激酶(MAPK)途径的“守门员”MEK1(也称为 MAP2K1)就是这样一个例子,它通过上游激酶的磷酸化作用来传递信号。原则上,自上而下的质谱法可以精确表征完整的 MEK1 蛋白异构体,但能够对 43 kDa 蛋白质离子上不稳定修饰进行特异性表征的片段化方法会导致过于密集的串联质谱。通过使用称为单个离子质谱的电荷检测方法,我们展示了如何可重复地处理复杂的磷酸化蛋白异构体混合物及其片段离子,从而通过在通路中绘制蛋白异构体图谱来提供信号活性的“鸟瞰图”。使用这种方法,在耐药转移性黑色素瘤的细胞模型中确定了 MEK1 上 0-4 个磷酸化的总体化学计量和分布。这种方法可以推广到其他多修饰的蛋白异构体,对于这些蛋白异构体,PTM 组合是其功能和药物作用的关键。